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ABSTRACT
Objectives: To test the feasibility of conducting a
controlled trial into the effectiveness of a self-
management programme integrated into stroke
rehabilitation.
Design: A feasibility cluster-randomised design was
utilised with stroke rehabilitation teams as units of
randomisation.
Setting: Community-based stroke rehabilitation teams
in London.
Participants: 78 patients with a diagnosis of stroke
requiring community based rehabilitation.
Intervention: The intervention consisted of an
individualised approach to self-management based on
self-efficacy. Clinicians were trained to integrate defined
self-management principles into scheduled
rehabilitation sessions, supported by a patient-held
workbook.
Main outcomes measures: Patient measures of
quality of life, mood, self-efficacy and functional
capacity, and health and social care utilisation, were
carried out by blinded assessors at baseline, 6 weeks
and 12 weeks. Fidelity and acceptability of the delivery
were evaluated by observation and interviews.
Results: 4 community stroke rehabilitation teams were
recruited, and received a total of 317 stroke referrals
over 14 months. Of these, 138 met trial eligibility
criteria and 78 participants were finally recruited
(56.5%). Demographic and baseline outcome
measures were similar between intervention and
control arms, with the exception of age. All outcome
measures were feasible to use and clinical data at
12 weeks were completed for 66/78 participants (85%;
95% CI 75% to 92%). There was no significant
difference in any of the outcomes between the arms of
the trial, but measures of functional capacity and self-
efficacy showed responsiveness to the intervention.
Observation and interview data confirmed acceptability
and fidelity of delivery according to predetermined
criteria. Costs varied by site.
Conclusions: It was feasible to integrate a stroke self-
management programme into community
rehabilitation, using key principles. Some data were
lost to follow-up, but overall results support the need
for conducting further research in this area and provide
data to support the design of a definitive trial.
Trial registration number: ISRCTN42534180.
INTRODUCTION
Signiﬁcant improvements have been made in
the quality and effectiveness of acute stroke
care across the developed world.1–3 But vari-
ation in the availability of post-hospital
rehabilitation and support for self-managed
activities still exists,3 4 and the prevalence of
mood disorders and social isolation post-
stroke remains high.5–7 As the overall global
burden of stroke increases,1 expenditure on
the direct and indirect costs of stroke care is
likely to rise, and in the UK this currently
constitutes 5% of the total National Health
Service (NHS) budget (£8 billion).8 Stroke
and associated care models are still largely
deﬁned by acute medical ideologies and
there is an inequity in attention to address
long-term psychological and social seque-
lae.9–11 Arguably, unmet needs post-stroke
could be exacerbated by care models that
foster dependency on professional expertise
in the acute stages, combined with a paucity
of programmes to facilitate coping and self-
management in the longer term.
One alternative to existing care models is
the use of self-management programmes
(SMPs) that build on growing evidence from
systematic reviews in other long-term condi-
tions.12–15 SMPs can be ‘provider-based’,
Strengths and limitations of this study
▪ This is the first feasibility trial of an integrated
approach to stroke self-management; study
recruitment and findings support further research
to test the intervention in a definitive trial.
▪ Community stroke rehabilitation teams had a
high turnover of staff, and training needs were
higher than anticipated, but intervention fidelity
was maintained.
▪ The intervention requires some modification to be
more accessible for those patients with cognitive
and communication impairments, and for those
having less than six sessions of rehabilitation.
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delivered by healthcare professionals integrated into
usual care, or ‘patient-based’, when supplied in addition
to care through group or individual education.13–16
Broadly, self-management focuses on those actions indi-
viduals and others take to mitigate the effects of a long-
term condition, and to maintain the best possible
quality of life.12–14 The variation in programmes makes
it difﬁcult to compare outcomes, but effective SMPs can
improve mental well-being and quality of life, and
reduce hospital readmission rates.12–16
The UK National Stroke Strategy, in 2007, advocated
self-management initiatives to address long-term unmet
needs,17 and national guidance recommends that all
patients be offered training in self-management skills.18
Research to develop and evaluate stroke SMPs mainly
comprises feasibility and phase II trials of group-based
programmes, which, while demonstrating some impact
on function, mood and quality of life,9 19 20 will not be
accessible for certain patients with communication and
cognitive impairments.21 We hypothesised that an indivi-
dualised stroke self-management intervention that can
be integrated into existing rehabilitation may extend the
reach to more patients.11 19 22
Following the Medical Research Council Framework for
the Development and Evaluation of Complex
Interventions,23 several studies have been conducted to
inform the development of an individualised SMP.22 24
The Bridges stroke SMP is based on social cognition
theory and self-efﬁcacy,25 26 and incorporates a patient-
held workbook used by rehabilitation professionals to
support self-management skills. Studies have demonstrated
preliminary proof of concept and feasibility when provided
in addition to rehabilitation.22 24 However, an SMP deliv-
ered in addition to routine stroke rehabilitation has cost
and time implications, especially when utilising an indivi-
dualised approach. If the same programme could be inte-
grated into existing rehabilitation, this may offer a solution
that could be both clinically valuable and cost-effective.
The aim of the study was to test the feasibility of con-
ducting a cluster-randomised controlled trial into the
effectiveness of a stroke SMP (Bridges) integrated into
community rehabilitation. We aimed to evaluate key trial
parameters such as recruitment and retention of partici-
pants, randomisation, utility and sensitivity of outcome
measures, levels of missing data and preliminary indica-
tions of effectiveness to inform calculation of a sample
size for powering a full trial. An estimation of resources
required to deliver the intervention and indications of
likely cost-effectiveness were also investigated. Fidelity of
the intervention delivery, training required and accept-
ability of the intervention to patients and clinicians were
evaluated.
METHODS
Design
A feasibility cluster-randomised design with a nested
process evaluation was utilised with community stroke
rehabilitation (CSR) teams as units of randomisation.
Sites were eligible if they comprised multiprofessional
teams with stroke specialist skills delivering post-hospital
rehabilitation according to quality criteria set out in UK
National Clinical Guidelines for Stroke.18 Current
models of CSR in the UK provide rehabilitation by
therapists (occupational therapists, physiotherapists and
speech and language therapists) and non-professional
support workers in patients’ homes.
Selection of sites
Twenty-one CSR teams from outer and inner London
boroughs with ethnically and socially diverse populations
were sent information about the study via a group email
used for a pan-London Stroke Rehabilitation Network.
Six teams agreed to take part and four teams were
selected as they had not taken part in any previous self-
management training in the previous 12 months, and
met all other eligibility criteria. Team consent was
obtained from the lead clinician acting as a cluster
guardian.
Randomisation
Allocation of CSR teams to either an intervention or
control cluster was carried out once teams had been
recruited and given consent to participate by a local clin-
ical trials unit via simple randomisation at 1:1 ratio
without matching.
Intervention
Intervention site teams undertook training on theory,
research and practical application of the Bridges SMP.
Training delivery in intervention sites adhered to a pre-
determined protocol based on seven key principles of
the SMP; these were developed through previous
research and in consultation with key stakeholders
(table 1).22 24
The Bridges SMP aimed to be distinct from routine
stroke rehabilitation provision in two main ways:
1. One-to-one rehabilitation sessions using seven princi-
ples integrated into each therapy session to support
self-management activities.
2. A stroke workbook that included vignettes, activities,
ideas and solutions from other stroke survivors for
successful self-management, and space to record and
reﬂect on goals and progress.
Recruitment
Consecutive patients with stroke referred for CSR were
screened by the community rehabilitation teams,
recruited within 2 weeks of referral to the CSR team and
consented by research staff not blinded to allocation.
Patients were eligible if they had a conﬁrmed diagnosis
of stroke and could follow a two-stage command such as
close your eyes and nod your head, and read simple text
and/or have a carer to assist. Criteria were informed by
previous research.22 24
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Stroke participants allocated to the intervention clus-
ters were introduced to the stroke workbook and the
seven key principles of self-management by the therapist
integrated into existing CSR sessions. Participants in
control sites received CSR as usual, which included
access to physiotherapy, occupational therapy, and
speech and language therapy, if required.
Sample size
As this was a feasibility study, a prospective sample size
calculation was not conducted. We aimed to recruit 80
stroke participants across the four sites over 14 months,
which appeared realistic given the teams’ referral rates.
Assessments
Data were collected in participants’ homes by research
assessors blinded to group allocation. Clinical outcomes
were collected at baseline (within 2 weeks from starting
rehabilitation), 6 weeks and 12 weeks after baseline.
Feasibility, fidelity and acceptability
The feasibility of recruiting and retaining participants
was assessed from study records, and characteristics of
those who were not eligible, consent and completion
rates were analysed. Participants’ age, sex, social support,
socioeconomic status and medical history, were described
and compared between groups, to test randomisation.
Fidelity and acceptability of the delivery of the inter-
vention were determined by observing a proportion of
rehabilitation sessions, using a checklist to record
patient and professional activities and behaviours against
each principle component of the SMP. The checklist was
piloted to enable a method to compare self-
management support delivered in intervention and
control sites that could be used in a larger trial. Patients
and clinicians were interviewed in each site, to compare
their experiences and understanding of self-
management; those in the intervention site were specif-
ically asked about the feasibility and acceptability of
using self-management strategies and workbook.
Clinical outcomes
Clinical measures found sensitive to change in previous
self-management trials and validated in stroke popula-
tions were utilised,9 20 24 and included the Stroke and
Aphasia Quality of Life (SAQOL) scale,27 Nottingham
Extended Activities of Daily Living Scale (NEADL) of
functional ability,28 Stroke Self-Efﬁcacy Questionnaire
(SSEQ),29 30 and Hospital Anxiety and Depression Scale
(HAD).31 The Medical Outcomes Trust’s Short Form 12
(SF-12) was included to provide a generic measure
Table 1 Seven key principles of the Bridges stroke self-management programme
Key principle An example of what might be observed to demonstrate use of key principle
Problem solving
Not being given solutions but encouraged
to come up with ideas and strategies
Clinician reminds patient about how the patient has earlier found ways around a
problem or challenge, for example, “I remember when you had to work really
hard to do ‘x’—how did you manage that, is there any way you can use the same
skills now?”
Reflection
Attributing changes and progress to
personal effort/not skills of therapist
Clinician encourages regular reflection in workbook to capture changes and
monitor how progress is being made, for example, highlighting the value of
reflecting on progress: “It will help to have a reminder about all the things you
have managed to do, however small”
Goal setting
Avoiding therapy-led goals, encouraging
small steps for mastery experiences and
longer term goals
Patient is encouraged to think of small things they could do towards their goal,
instead of being discouraged from an ‘unrealistic target’, for example, “What’s a
small thing you could do this week that might help you towards that?”
Accessing resources
Using resources available to achieve
personal goals
Clinician uses open style coaching questions, for example, “What support could
you use to help you get to that?”
Self-discovery
Finding out new ways of doing things and
trying out different activities
Clinician asks about the ways the patient managed to do challenging things
before their stroke and what strategies have worked for them previously, for
example, clinician is heard discussing the need to take some risks, and try
things out and the benefit to learning about what is possible
Activity
Encouraging activity, however small
Clinician asks what they have managed to do in the last week, what they are
most pleased with in terms of their activity, for example, “What have you
managed to do in the past week that you are really pleased about?”
Knowledge
Knowledge about stroke, but also about
self
Clinician explores what the patient knows about their stroke, what they would like
to know and any concerns that patient feels might be hampering rehabilitation,
for example, “Are there any things that you are worried might be affecting your
rehab? Is there one small thing we can work towards that might help?”
Jones F, et al. BMJ Open 2016;6:e008900. doi:10.1136/bmjopen-2015-008900 3
Open Access
F
ig
u
re
1
S
tu
dy
flo
w
di
ag
ra
m
.
4 Jones F, et al. BMJ Open 2016;6:e008900. doi:10.1136/bmjopen-2015-008900
Open Access
health-related quality of life.32 Ease of data capture and
levels of missing data were assessed for each outcome
measure.
Although the study was not powered, a statistical ana-
lysis was conducted to gain a preliminary indication of
effectiveness and of the feasibility of such analysis. The
analysis enabled an assessment of the sensitivity of differ-
ent outcome measures and provided a basis for a sample
size calculation for the full trial.
Statistical analysis
Considering feasibility, we compared levels of missing
data between intervention and control sites using
Fisher’s exact test. In order to adjust for age, a multilevel
regression model was ﬁtted to each clinical outcome.
This is a common approach to cluster-randomised clin-
ical trials, and utilises all data, even if a participant is
missing some. Group allocation was purely on the basis
of site, forming an intention-to-treat analysis.
Interparticipant variability was represented as a random
intercept, and age, time and group allocation were
included as ﬁxed effects. Group differences were quanti-
ﬁed at 6 and 12 weeks, and a composite null hypothesis
that both were equal to zero was assessed by Wald tests.
This represents no mean difference between groups in
how the outcomes change over time. These analyses
were conducted in Stata V.11.2 software (StataCorp,
College Station, Texas, USA), using command ‘xtmixed’.
Sample size calculations for a future trial were calcu-
lated using Stata software (command ‘sampsi’), assum-
ing SDs observed in this study for NEADL and
SAQOL, 80% power requirement and a range of puta-
tive minimum clinically important differences
(MCIDs): NEADL from 2 to 5 in steps of 0.1, and
SAQOL from 0.1 to 0.5 in steps of 0.01.
Economic analysis
To estimate the resources involved in delivering stroke
rehabilitation in each site, data were collected at individ-
ual patient level from therapist records on the number
of CSR sessions, and face-to-face contact time in
minutes. Physical resources were converted to costs
using validated national unit costs, in British pounds,
2012.33 Costs associated with patient-related non-face-
to-face time was calculated under three alternative
assumptions. Total costs were compared across sites.
The feasibility of capturing health and social care util-
isation from participants was assessed using a bespoke
self-report questionnaire administered to participants at
weeks 6 and 12. Items included contacts with general
practitioner (GP), practice nurse or other professionals,
social care, and help from family and friends. The
purpose was to explore if use of SMP reduced demands
on other services, compared with the control group.
EuroQol (EQ-5D) health state utility weights, using a
published transformation33 of the SF-12 proﬁle measure
of quality of life, was to be tested for deriving
quality-adjusted life year (QALY) gains.
RESULTS
Intervention fidelity and acceptability
Overall, 63 occupational therapists, physiotherapists,
speech and language therapists, and rehabilitation
support workers, received training. This number was
higher than expected because of clinician turnover.
The feasibility of monitoring intervention ﬁdelity was
evaluated through observations of a consecutive sample
of 14 participants (18%, control n=7, intervention n=7).
The checklist was feasible to use and identiﬁed whether
CSR incorporated behaviours and activities relating to
Table 2 Characteristics of study participants
Intervention
(n=40) Control (n=38)
Age 61.79±16.03 68.82±10.28
Sex
Male 20 (50%) 25 (65.8%)
Female 20 (50%) 13 (34.2%)
Time post-stroke onset (days)
Minimum,
maximum
31, 1369 17, 1105
Median (IQR) 76 (44.5–130.5) 116 (46–170.5)
Cohabitants
Living alone 11/38 (29%) 11/37 (30%)
Spouse only 18/38 (47%) 20/37 (54%)
Others 9/38 (24%) 6/37 (16%)
Carers
None 4/38 (10%) 6/37 (16%)
Professional 9/38 (24%) 11/37 (30%)
Family and friends
only
25/38 (66%) 20/37 (54%)
Housing
House 21/38 (55%) 23/37 (62%)
Apartment 15/38 (40%) 9/37 (24%)
Other 2/38 (5%) 5/37 (14%)
Ethnicity
White British 17/38 (45%) 19/37 (51%)
Other White 3/38 (8%) 8/37 (22%)
Black Caribbean 10/38 (26%) 6/37 (16%)
Other 8/38 (21%) 4/37 (11%)
NEADL 29.89±14.38 30.78±17.01
HADS-A 7.54±5.27 7.43±5.10
HADS-D 6.90±4.22 7.11±3.44
SAQOL mean 3.37±0.77 3.25±0.81
SAQOL physical 3.40±0.87 3.05±1.05
SAQOL
communication
4.00±1.08 4.09±0.90
SAQOL psychological 3.05±1.00 3.01±1.01
SF-12 physical 34.00±8.53 30.86±10.10
SF-12 mental 46.84±12.57 40.96±14.24
SSEQ 25.95±8.64 23.51±9.72
Values are proportion (percentage) or mean±SD, unless
otherwise indicated.
HADS-A, Hospital Anxiety and Depression Scale—Anxiety scores;
HADS-D, Hospital Anxiety and Depression Scale—Depression
scores; NEADL, Nottingham Extended Activities of Daily Living
Scale; SAQOL, Stroke and Aphasia Quality of Life scores; SF-12,
Short Form 12 questionnaire; SSEQ, Stroke Self-Efficacy
Questionnaire.
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core self-management principles. Clinicians in the inter-
vention sites showed use of between ﬁve and seven self-
management principles, whereas those in the control
site showed evidence of using two or less.
A consecutive sample of patients (n=23) were inter-
viewed and focus groups were carried out with all
clinicians (n=34) including occupational therapists,
physiotherapists, speech and language therapists,
and rehabilitation support workers across sites, at the
end of the trial, to explore intervention feasibility and
acceptability. Findings showed shared understanding
of self-management in patients and clinicians within
the intervention clusters, which reﬂected the under-
lying principles of the SMP and will be reported more
fully elsewhere.
Feasibility
Recruitment rates: Four sites were recruited from six CSR
teams in London that expressed an interest and were eli-
gible; excluded sites had either previously taken part in
self-management training or were likely to undergo sig-
niﬁcant reorganisation during the trial period of
22 months. Participant recruitment occurred between
July 2012 and August 2013, 138/317 patients (44%)
were eligible to participate across four sites. Recruitment
took 14 months, which was longer than the anticipated
10 months. This was due to restructuring of some com-
munity services and a requirement for further training
for new staff. Of those eligible and invited to participate,
78/138 (56%) consented and were recruited to the trial
(at a rate of 5.57/month). Control sites recruited n=38
compared with n=40 in intervention sites. The main
reason for non-eligibility was patients not requiring six
rehabilitation sessions or more (58%), and patients with
cognitive and communication impairments (17%). The
latter were excluded as a certain minimum level of cog-
nitive and communication ability (ie, ability to follow a
verbal or non-verbal two-stage command) was required
for the intervention, which is based on cognitive inter-
action between practitioner and stroke survivor.
Completion rates
The research protocol was successfully delivered and
outcome assessors remained blinded to the intervention
throughout the duration of the trial. Figure 1 shows
rates of completion varied slightly between control and
intervention sites. Thirty-nine participants (98%) com-
pleted baseline measures and 36 participants completed
week 12 outcome measures (90%) in intervention sites,
compared with 35 (92%) completing baseline outcomes
and 30 (79%) completing week 12 outcomes measures
in control sites. Reasons for withdrawal included ill
health and change in family circumstances, with only
three cases of withdrawal due to burden of outcome
measurement (nature of the questions (n=1) and the
volume of questions (n=2)).
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Randomisation
Participant characteristics
Table 2 shows an even distribution of men and women
in intervention sites, but more men took part in the
control sites. Days post-stroke data were missing in 8/78
participants. Of note is the wide variation in the length
of time since stroke onset. Demographic variables
including ethnicity and social circumstances were com-
parable between intervention and control sites, with the
exception of age. Baseline data were complete for
74 (95%) out of 78 participants (95% CI 87% to 99%),
with no signiﬁcant difference between study arms (98%
intervention vs 92% control, p=0.35, Fisher’s exact test).
Clinical outcomes
Table 3 shows means and SDs for all outcomes at each
time point (baseline, 6 weeks and 12 weeks). Table 3
shows clinical data at 12 weeks completed for 66/78 par-
ticipants (83%; 95% CI 75% to 92%), and there was no
signiﬁcant difference in outcomes between the arms
of the trial for this (p=0.22, Fisher’s exact test). The
modelling revealed no signiﬁcant difference between
intervention and controls on any outcome that was
tested, although the intervention sites showed more
consistent improvement in self-efﬁcacy (SSEQ) and
functional capacity (NEADL) than did control sites
(table 4). If the intervention is aimed at changing
self-efﬁcacy and conﬁdence to self-manage, then func-
tional capacity, which measures actual performance,
could be a feasible clinical endpoint in a future fully
powered trial.
Sample size calculation for a definitive study
A sample size calculation for a future cluster-randomised
controlled trial can be based on the NEADL at 12 weeks
with MCIDs suggested as 6.1. The mean (SD) for
NEADL was 35.5 (16.86) in the intervention group and
32.1 (19.05) in the control group, and Pearson correl-
ation between baseline and 12-week follow-up NEADL
was 0.78. Sites in this study were similar for NEADL
apart from one site, which had a lower mean (but this
seems to have been driven by just two participants);
therefore, we are not able to make a precise estimate of
intraclass correlation for future studies, though it
appears to be small. If we assume intraclass correlation
of zero in the sample size calculation, this effectively
uses a calculation for parallel-arms randomised con-
trolled trials, and the MCID for NEADL would require
137 in each arm.34 Assuming a pessimistic completion
rate at 12 weeks of 75%, the lower end of the CI from
this study’s data, this requires consenting 183 partici-
pants per arm for NEADL, which implies allocating nine
sites per arm for NEADL alone.
Resources and costs of the intervention
Rehabilitation records were available for 73 patients.
Total rehabilitation inputs were similar in the two
control sites (24 therapy hours per patient). However, a
difference was found between the two intervention sites
(20.1 vs 50.7 therapy hours). Intervention sites reported
a proportionately higher use of therapy assistants than
control site (table 5). Costs of patient-facing time
ranged from £600 in the low resource use intervention
site to £1667 in the high resource use intervention site.
The costs of the two control sites were similar (£754
and £763). Total costs for control sites (mean of two
sites) ranged from £930 to £1459, depending on the
assumptions made about the ratios of patient-facing to
patient-related non-face-to-face costs. The equivalent
range for the low resource use intervention site was
£721–£1103, and for the high resource use intervention
site it was £1987–£3012 (table 5).
Table 4 Outcomes analysis
Outcome
Difference at
12 weeks
Change
from
baseline
Change
adjusted
for age
Multilevel model
Change at
6 weeks,
adjusted for age
Change at
12 weeks,
adjusted for age
Composite
p value
NEADL 3.47 4.37 3.77 2.89 4.51 0.14
HADS-A* −0.85 −0.61 −0.23 −0.06 −0.45 0.87
HADS-D* −0.96 −0.55 −0.38 −0.93 −0.59 0.36
SAQOL mean 0.26 0.05 0.02 0.02 0.05 0.91
SAQOL physical 0.32 −0.10 −0.09 −0.03 −0.08 0.87
SAQOL communication 0.15 0.17 0.14 0.13 0.16 0.52
SAQOL psychological 0.26 0.15 0.08 0.04 0.14 0.72
SF-12 physical 3.13 −0.31 −0.37 0.61 −0.07 0.91
SF-12 mental 3.36 −1.16 −1.77 −3.92 −2.20 0.31
SSEQ 4.83 1.91 1.11 2.20 2.17 0.30
Values are expressed as mean differences between intervention and control sites. Output from the multilevel model comparing changes
(adjusted for age) across collected outcome measures.
*High scores on HADS indicate worse morbidity, for all other scales this is reversed.
NEADL, Nottingham Extended Activities of Daily Living Scale; HADS-A, Hospital Anxiety and Depression Scale—Anxiety scores; HADS-D,
Hospital Anxiety and Depression Scale—Depression scores; SAQOL, Stroke and Aphasia Quality of Life scores; SF-12, Short Form 12
questionnaire; SSEQ, Stroke Self-Efficacy Questionnaire.
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Patient level use of other health and social services at
6-week and 12-week follow-up were available for 63 of the
73 (88%) participants; the remainder were either lost to
follow-up or withdrew. There were relatively few missing
data items. The only services used by more than 10% of
respondents were GPs, nurses, and hospital outpatient
and emergency departments (data not shown); all other
services, including social care, were not accessed by more
than 90% of participants. Comparisons between sites of
total costs of other service utilisation revealed no signiﬁ-
cant differences between any pair of sites. However, when
only stroke-related service use was considered, the other
health and social service costs of patients in the low-cost
intervention site were higher than in all the other sites
(£1291 vs £514 in the high cost intervention site, and
£529 and £898 in the two control sites).
DISCUSSION
This is the ﬁrst study to test the feasibility of conducting
a cluster-randomised controlled trial into the effective-
ness of a stroke SMP integrated into post-hospital
rehabilitation. Overall, the design, using a nested
process evaluation, was found to be feasible and the
intervention was delivered according to predetermined
markers of ﬁdelity.
Recruitment rate at 25% was higher than previous
research (18%).24 But patients who required fewer
than six sessions were the main reason for exclusion
(58%). This is a limitation of this study and our previ-
ous research, but was chosen following discussion with
CSR teams based on the premise that patients requir-
ing less than six sessions would be less likely to have
ongoing rehabilitation needs and would usually be
managed by assessment and one-off advice. However,
further research to adapt self-management interven-
tions to be delivered in fewer number of sessions
while delivering the same impact, such as that devel-
oped by Harwood et al, are now warranted.35
Participants with aphasia and other cognitive impair-
ments were also recruited at a lower rate and previous
research using provider-based stroke SMPs has
included low numbers of people with aphasia.9
Participants were also excluded due to low mood, not
engaging in therapy and social issues, and 12 poten-
tial participants were excluded with no clear reason
other than they were less compliant or more challen-
ging. We suspect there were issues of potential gate
keeping and selection of ‘model’ participants for the
trials illustrated in another study,36 which highlights
the need for training to include methods and prac-
tical solutions of extending the SMP to more patients.
Outcomes measuring functional capacity (NEADL)
and self-efﬁcacy (SSEQ) showed most sensitivity to
change in the intervention compared with control sites.
This provides some validation of the aims of Bridges
stroke SMP, which uses self-efﬁcacy principles to facili-
tate a change in functional capacity and self-
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management. Functional capacity and mood have been
shown to be closely associated with self-efﬁcacy post-
stroke, but the causal relationship has not been estab-
lished.11 37 However, we suggest a measure of functional
capacity such as the NEADL as a primary outcome with
secondary measures of mood, quality of life and self-
efﬁcacy, is warranted in future self-management trials. At
least 18 clusters would be required recruiting 20 partici-
pants per site to evaluate effectiveness of this stroke SMP
in a full trial.
A number of economic ﬁndings were relevant to a full
trial. In particular, the resource implications of the inter-
vention appeared very different in the two sites. The
composition of teams, particularly the ratio of profes-
sional to support staff also require further evaluation.
The tool for collecting data on other service use worked
well, but the burden on participants might have been
reduced by concentrating on services (including GP,
nurse, A&E, nurse inpatient) used most frequently, and
only on those that were stroke-related. The SF-12 scores
were not signiﬁcantly different between groups, so
QALYs were not calculated, although a larger trial may
identify differences.
The quality of training given to clinicians in the
intervention sites was central to the delivery of the
SMP as intended, but was more labour intensive than
expected due to high staff turnover. However, com-
pared with recent large-scale trials of provider-based
SMPs,38–40 clinicians from the intervention sites
engaged in training, and enacted behaviours aligned
with predetermined markers of self-management
support. Nonetheless, training costs are a major con-
sideration for SMP implementation, and less costly
methods of training, such as online resources and
peer learning utilising SMP champions, could be
employed in a full trial.
Overall, the study was completed with minimal data
lost to follow-up, and the trial design could be replicated
in a larger deﬁnitive trial. By reducing the number of ses-
sions required, addressing accessibility of the workbook
and adapting the intervention for people with cognitive
impairments, recruitment rates could increase further.
Given these recommendations, our results support the
need for conducting further research in this area, and
provide data to support the design of a deﬁnitive trial.
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